BRAF mutation in papillary thyroid cancer-Prevalence and clinical correlation in a South-East Asian cohort-Reference-Cited by-同舟云学术

BRAF mutation in papillary thyroid cancer-Prevalence and clinical correlation in a South-East Asian cohort

Published:2018-11-28 Issue:2 Volume:44 Page:114-123
ISSN:1749-4478
Container-title:Clinical Otolaryngology
language:en
Short-container-title:Clin Otolaryngol

Author:

Goh Xueying¹^ORCID,Lum Jeffery²,Yang Samantha Peiling³⁴,Chionh Siok Bee³,Koay Evelyn²⁵⁶,Chiu Lily⁶,Parameswaran Rajeev⁷,Ngiam Kee Yuan⁷,Loh Thomas Kwok Seng¹⁸,Nga Min En²⁵,Lim Chwee Ming¹⁸^ORCID

Affiliation:

1. Department of Otolaryngology - Head and Neck Surgery; National University Hospital; Singapore

2. Department of Pathology; National University Hospital; Singapore

3. Division of Endocrinology, University Medicine Cluster; National University Hospital; Singapore

4. Department of Medicine, Yong Loo Lin School of Medicine; National University of Singapore; Singapore

5. Department of Pathology, Yong Loo Lin School of Medicine; National University of Singapore; Singapore

6. Department of Laboratory Medicine; National University Hospital; Singapore

7. Division of General Surgery, University Surgical Cluster; National University Hospital; Singapore

8. Department of Otolaryngology - Head and Neck Surgery, Yong Loo Lin School of Medicine; National University of Singapore; Singapore

Funder

National Medical Research Council

National University Cancer Institute of Singapore

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/coa.13238/fullpdf

Reference58 articles.

1. Increasing incidence of thyroid cancer in the United States, 1973-2002;Davies;JAMA,2014

2. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005;Enewold;Cancer Epidemiol Biomark Prev,2009

3. Thyroid cancer: burden of illness and management of disease;Brown;J Cancer,2011

4. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer;Xing;J Clin Oncol,2015

5. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma;Kim;Clin Endocrinol,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation analysis between BRAFV600E mutation and ultrasonic and clinical features of papillary thyroid cancer;Heliyon;2024-05

2. BRAF V600E Mutation in Thyroid Carcinoma: A Large-Scale Study in Han Chinese Population;2024-03-15

3. Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital;The Application of Clinical Genetics;2023-05

4. MRI-Based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma;Journal of Multidisciplinary Healthcare;2023-01

5. Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies;International Journal of Molecular Sciences;2022-12-09